This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novelix Pharmaceuticals, Inc.. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: Edgar Selzer: Innovator in Tumor Growth Inhibition
Introduction
Edgar Selzer is a notable inventor based in St. Andrae-Woerdern, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods and compositions aimed at inhibiting tumor growth. With a total of 2 patents to his name, Selzer's work is focused on innovative solutions for serious health issues.
Latest Patents
Selzer's latest patents include groundbreaking research on novel betulinic acid derivatives. These derivatives exhibit increased activity for the treatment of carcinomas and HIV diseases. His inventions not only detail the methods for preparing these derivatives but also emphasize their potential use as pharmaceuticals. This work represents a significant advancement in cancer treatment and antiviral therapies.
Career Highlights
Throughout his career, Selzer has been associated with Novelix Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His dedication to research and development has positioned him as a key figure in the fight against cancer and other serious diseases.
Collaborations
Selzer has collaborated with esteemed colleagues such as Burkhard Jansen and Reinhard Paschke. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.
Conclusion
Edgar Selzer's contributions to the field of pharmaceuticals, particularly in tumor growth inhibition, highlight his innovative spirit and commitment to improving health outcomes. His work continues to inspire advancements in medical research and treatment options.